Chemicals · Founded 1975 · www.atul.co.in · BSE 500027 · NSE ATUL LTD. · ISIN INE100A01010
No Notes Added Yet
Business
Atul Ltd. is an Indian integrated chemical company engaged in the production of a wide range of chemicals, including specialty chemicals, bulk chemicals, intermediates, and pharmaceuticals. The company manufactures products across various value chains, serving diverse industries such as agriculture, paints and coatings, adhesives, construction, personal care, textiles, polymers, and pharmaceuticals. Its core business model revolves around developing and manufacturing complex chemical products, often involving multiple steps of synthesis, and supplying them to industrial customers domestically and internationally. Atul generates revenue through the sale of these chemicals.
Revenue Mix
Atul Ltd. primarily operates through two major segments:
Life Science Chemicals: This segment includes agrochemicals, aroma chemicals, pharmaceuticals (APIs and intermediates), and bulk chemicals. Products here often involve complex synthesis and serve regulated industries.
Performance and Other Chemicals: This segment comprises polymers, epoxy resins and hardeners, textile dyes and intermediates, friction materials, and other specialty chemicals for various industrial applications.
While specific revenue contributions can fluctuate, the company maintains a diversified portfolio aimed at reducing dependence on any single end-user industry or product line.
Industry
Atul operates in the diverse and often fragmented Indian chemicals sector. The industry includes both large integrated players and numerous smaller specialty producers. Atul is positioned as a diversified specialty chemical company with a strong focus on backward integration and value-added products. It competes with global chemical majors in certain product lines and with domestic players across its various segments. Its positioning benefits from a wide product portfolio, long-standing customer relationships, and a focus on R&D for new product development and process innovation, allowing it to cater to niche and critical industrial needs.
MOAT
Atul's competitive advantages stem from:
Diversified Product Portfolio: A wide range of products across multiple value chains and end-user industries provides resilience against downturns in any single segment.
Backward Integration: Significant backward integration in many of its processes helps in cost control, ensures raw material security, and improves quality consistency.
R&D and Technical Expertise: Capabilities in process chemistry and product development allow for the manufacturing of complex, specialized chemicals and continuous innovation.
Long-standing Customer Relationships: Established relationships with key industrial customers, both domestic and international, built on reliability and quality.
Regulatory Approvals: For products in segments like agrochemicals and pharmaceuticals, obtaining and maintaining necessary regulatory approvals provides an entry barrier.
Growth Drivers
Demand from End-user Industries: Growth in key end-user sectors like agriculture, construction, automotive, pharmaceuticals, and consumer goods in India and globally.
"China Plus One" Strategy: Global manufacturers diversifying their supply chains away from China could lead to increased export opportunities for Indian chemical companies like Atul.
Capacity Expansion and New Product Launches: Ongoing capital expenditure to expand existing capacities and introduce new, value-added products can drive revenue growth.
Import Substitution: Government initiatives and domestic industry push for self-reliance in chemicals can create opportunities for local manufacturers.
Increasing R&D Focus: Investment in R&D to develop innovative and sustainable solutions, catering to evolving industry demands and environmental regulations.
Risks
Raw Material Price Volatility: Fluctuations in the prices of key crude oil derivatives and other chemical intermediates can impact profitability.
Environmental Regulations: Strict and evolving environmental compliance standards and potential remediation costs pose operational and financial risks.
Global Economic Slowdown: A downturn in global manufacturing or specific end-user industries could reduce demand for Atul's products.
Currency Fluctuations: As a company with significant exports and imports, adverse movements in foreign exchange rates can affect financial performance.
Intense Competition: Competition from both domestic and international players can lead to pricing pressure and margin erosion.
Technological Obsolescence: Failure to keep pace with new technologies or process innovations could impact competitiveness.
Management & Ownership
Atul Ltd. is promoted by the Lalbhai Group, a prominent industrial house in India with a long history. The company has a professional management team with experience in the chemical sector. The promoter family holds a significant stake in the company, ensuring aligned interests, while institutional and public shareholders comprise the remainder of the ownership structure. The management is generally perceived as conservative and focused on sustainable growth and operational efficiency.
Outlook
Atul Ltd. is well-positioned in the growing Indian chemical industry, benefiting from its diversified product portfolio, backward integration, and R&D capabilities. The company's focus on specialty chemicals and critical intermediates provides some resilience against commodity cycles. Growth is likely to be driven by increasing domestic demand from end-user industries, potential benefits from global supply chain diversification ("China +1"), and strategic capacity expansions. However, the outlook is balanced by inherent industry risks such as raw material price volatility, stringent environmental regulations, and global economic fluctuations. The company's conservative management and continuous focus on operational efficiencies and product innovation suggest a stable long-term trajectory, though profitability can be influenced by macro factors and competitive intensity.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1138 | 1212 | 1322 | 1393 | 1417 | 1452 | 1478 | 1552 | 1574 | 1670 |
| Other Income | 15 | 13 | 13 | 32 | 16 | 49 | 26 | 49 | 39 | 90 |
| Total Income | 1153 | 1225 | 1335 | 1424 | 1433 | 1500 | 1504 | 1600 | 1612 | 1760 |
| Total Expenditure | 986 | 1065 | 1099 | 1150 | 1193 | 1229 | 1243 | 1284 | 1327 | 1389 |
| Operating Profit | 167 | 160 | 236 | 274 | 240 | 272 | 262 | 316 | 286 | 370 |
| Interest | 2 | 5 | 5 | 9 | 4 | 5 | 5 | 5 | 4 | 4 |
| Depreciation | 61 | 76 | 77 | 78 | 81 | 82 | 82 | 81 | 80 | 79 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 103 | 80 | 154 | 188 | 155 | 185 | 175 | 230 | 202 | 287 |
| Provision for Tax | 33 | 24 | 46 | 51 | 41 | 56 | 45 | 49 | 40 | 78 |
| Profit After Tax | 70 | 55 | 109 | 136 | 114 | 129 | 130 | 181 | 162 | 209 |
| Adjustments | 1 | 3 | 3 | 0 | -5 | -2 | -3 | -2 | -1 | 1 |
| Profit After Adjustments | 71 | 58 | 112 | 137 | 109 | 127 | 128 | 179 | 161 | 210 |
| Adjusted Earnings Per Share | 24.1 | 19.8 | 38 | 46.5 | 36.9 | 43 | 43.4 | 60.9 | 54.6 | 71.4 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2656 | 2595 | 2834 | 3296 | 4038 | 4093 | 3731 | 5081 | 5428 | 4726 | 5583 | 6274 |
| Other Income | 20 | 34 | 53 | 26 | 35 | 78 | 111 | 78 | 115 | 61 | 109 | 204 |
| Total Income | 2677 | 2629 | 2886 | 3322 | 4073 | 4171 | 3843 | 5159 | 5542 | 4786 | 5692 | 6476 |
| Total Expenditure | 2265 | 2135 | 2324 | 2791 | 3271 | 3191 | 2823 | 4171 | 4653 | 4092 | 4670 | 5243 |
| Operating Profit | 412 | 494 | 562 | 531 | 802 | 980 | 1020 | 987 | 890 | 695 | 1022 | 1234 |
| Interest | 26 | 28 | 25 | 13 | 7 | 9 | 9 | 9 | 8 | 11 | 24 | 18 |
| Depreciation | 60 | 66 | 95 | 110 | 119 | 130 | 136 | 177 | 198 | 243 | 317 | 322 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 326 | 404 | 446 | 412 | 680 | 845 | 882 | 810 | 688 | 451 | 692 | 894 |
| Provision for Tax | 99 | 130 | 123 | 131 | 244 | 175 | 222 | 205 | 181 | 127 | 194 | 212 |
| Profit After Tax | 226 | 274 | 323 | 281 | 436 | 671 | 660 | 605 | 507 | 324 | 499 | 682 |
| Adjustments | 14 | -1 | -0 | -5 | -4 | -4 | -4 | -0 | 7 | -1 | -15 | -5 |
| Profit After Adjustments | 241 | 274 | 323 | 276 | 432 | 666 | 656 | 604 | 514 | 323 | 484 | 678 |
| Adjusted Earnings Per Share | 81.1 | 92.2 | 108.9 | 93.2 | 145.7 | 224.7 | 221.6 | 204.2 | 174.2 | 109.7 | 164.4 | 230.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 18% | 3% | 6% | 8% |
| Operating Profit CAGR | 47% | 1% | 1% | 10% |
| PAT CAGR | 54% | -6% | -6% | 8% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -8% | -0% | -6% | 13% |
| ROE Average | 9% | 9% | 12% | 16% |
| ROCE Average | 13% | 12% | 16% | 21% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1039 | 1615 | 1966 | 2244 | 2706 | 3155 | 3827 | 4429 | 4671 | 5114 | 5599 |
| Minority's Interest | 6 | 2 | 15 | 20 | 24 | 26 | 31 | 31 | 48 | 49 | 64 |
| Borrowings | 59 | 23 | 0 | 0 | 43 | 87 | 98 | 61 | 29 | 209 | 182 |
| Other Non-Current Liabilities | 82 | 119 | 158 | 176 | 194 | 144 | 174 | 175 | 163 | 203 | 254 |
| Total Current Liabilities | 638 | 706 | 672 | 672 | 828 | 945 | 1007 | 1207 | 1028 | 1005 | 1037 |
| Total Liabilities | 1823 | 2465 | 2812 | 3112 | 3795 | 4356 | 5136 | 5903 | 5940 | 6580 | 7135 |
| Fixed Assets | 514 | 758 | 1032 | 1036 | 1114 | 1122 | 1415 | 1631 | 1766 | 2789 | 2844 |
| Other Non-Current Assets | 269 | 649 | 568 | 618 | 767 | 940 | 956 | 1375 | 1894 | 1399 | 1193 |
| Total Current Assets | 1041 | 1059 | 1211 | 1459 | 1913 | 2295 | 2765 | 2897 | 2279 | 2392 | 3098 |
| Total Assets | 1823 | 2465 | 2812 | 3112 | 3795 | 4356 | 5136 | 5903 | 5940 | 6580 | 7135 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 18 | 31 | 18 | 23 | 43 | 38 | 26 | 47 | 58 | 38 | 60 |
| Cash Flow from Operating Activities | 306 | 401 | 392 | 356 | 404 | 881 | 718 | 231 | 707 | 667 | 603 |
| Cash Flow from Investing Activities | -167 | -375 | -173 | -130 | -407 | -783 | -646 | -168 | -469 | -683 | -495 |
| Cash Flow from Financing Activities | -124 | -39 | -212 | -207 | -1 | -111 | -52 | -57 | -257 | 38 | -118 |
| Net Cash Inflow / Outflow | 16 | -13 | 7 | 18 | -5 | -12 | 19 | 6 | -20 | 22 | -10 |
| Closing Cash & Cash Equivalent | 34 | 18 | 23 | 43 | 38 | 26 | 47 | 58 | 38 | 60 | 51 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 81.14 | 92.24 | 108.89 | 93.22 | 145.73 | 224.7 | 221.62 | 204.21 | 174.21 | 109.72 | 164.38 |
| CEPS(Rs) | 96.59 | 114.75 | 141.2 | 132.04 | 187.1 | 270.1 | 269.12 | 264.09 | 238.71 | 192.6 | 277.06 |
| DPS(Rs) | 8.5 | 10 | 10 | 12 | 15 | 27.5 | 20 | 25 | 32.5 | 20 | 25 |
| Book NAV/Share(Rs) | 350.29 | 544.43 | 662.82 | 756.54 | 912.24 | 1063.68 | 1293.17 | 1496.77 | 1582.98 | 1737.2 | 1901.67 |
| Core EBITDA Margin(%) | 13.84 | 16.67 | 17 | 15.13 | 18.99 | 22.04 | 24.15 | 17.67 | 14.05 | 13.18 | 15.99 |
| EBIT Margin(%) | 12.42 | 15.68 | 15.73 | 12.73 | 17.03 | 20.88 | 23.68 | 15.91 | 12.61 | 9.6 | 12.55 |
| Pre Tax Margin(%) | 11.51 | 14.68 | 14.89 | 12.35 | 16.85 | 20.65 | 23.43 | 15.73 | 12.47 | 9.37 | 12.13 |
| PAT Margin (%) | 8 | 9.96 | 10.79 | 8.43 | 10.8 | 16.39 | 17.54 | 11.75 | 9.18 | 6.74 | 8.73 |
| Cash Profit Margin (%) | 10.13 | 12.35 | 13.98 | 11.73 | 13.74 | 19.57 | 21.16 | 15.18 | 12.77 | 11.79 | 14.28 |
| ROA(%) | 12.43 | 12.79 | 12.25 | 9.5 | 12.63 | 16.46 | 13.91 | 10.96 | 8.56 | 5.18 | 7.27 |
| ROE(%) | 24.08 | 20.67 | 18.06 | 13.36 | 17.62 | 22.9 | 18.91 | 14.65 | 11.13 | 6.62 | 9.31 |
| ROCE(%) | 27.61 | 26.44 | 23.19 | 19.34 | 27.4 | 28.38 | 24.69 | 19.22 | 14.99 | 9.17 | 12.86 |
| Receivable days | 56.77 | 58.55 | 58.5 | 67.93 | 64.27 | 63.23 | 70.46 | 61.05 | 60.66 | 67.22 | 65.62 |
| Inventory Days | 54.83 | 55.85 | 51.59 | 45.42 | 41.73 | 45.26 | 53.22 | 51.7 | 54.7 | 53.41 | 43.06 |
| Payable days | 75.05 | 80.39 | 82.97 | 80.6 | 72.67 | 79.42 | 112.05 | 84.45 | 74.76 | 81.26 | 79.37 |
| PER(x) | 13.9 | 16.71 | 21.86 | 28.13 | 24.52 | 17.69 | 31.93 | 50.38 | 39.96 | 52.3 | 37.31 |
| Price/Book(x) | 3.22 | 2.83 | 3.59 | 3.47 | 3.92 | 3.74 | 5.47 | 6.87 | 4.4 | 3.3 | 3.23 |
| Dividend Yield(%) | 0.75 | 0.65 | 0.42 | 0.46 | 0.42 | 0.69 | 0.28 | 0.24 | 0.47 | 0.35 | 0.41 |
| EV/Net Sales(x) | 1.36 | 1.87 | 2.54 | 2.35 | 2.62 | 2.9 | 5.55 | 6.01 | 3.78 | 3.61 | 3.26 |
| EV/Core EBITDA(x) | 8.76 | 9.85 | 12.81 | 14.58 | 13.22 | 12.1 | 20.31 | 30.9 | 23.08 | 24.54 | 17.8 |
| Net Sales Growth(%) | 8.08 | -2.33 | 9.22 | 16.3 | 22.51 | 1.37 | -8.83 | 36.16 | 6.82 | -12.93 | 18.15 |
| EBIT Growth(%) | 2.79 | 22.99 | 9.08 | -9.82 | 63.47 | 24.29 | 4.85 | -8.09 | -15.04 | -33.64 | 55.18 |
| PAT Growth(%) | 2.72 | 21.25 | 17.89 | -13.02 | 57.4 | 53.87 | -0.89 | -8.38 | -16.22 | -36.02 | 53.9 |
| EPS Growth(%) | 9.79 | 13.68 | 18.06 | -14.39 | 56.33 | 54.19 | -1.37 | -7.85 | -14.69 | -37.02 | 49.81 |
| Debt/Equity(x) | 0.29 | 0.2 | 0.09 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 | 0.05 | 0.04 |
| Current Ratio(x) | 1.63 | 1.5 | 1.8 | 2.17 | 2.31 | 2.43 | 2.75 | 2.4 | 2.22 | 2.38 | 2.99 |
| Quick Ratio(x) | 0.98 | 0.89 | 1.18 | 1.56 | 1.69 | 1.9 | 2.16 | 1.68 | 1.45 | 1.77 | 2.28 |
| Interest Cover(x) | 13.67 | 15.69 | 18.72 | 33.36 | 92.81 | 90.94 | 95.3 | 89.3 | 88.07 | 41.67 | 29.88 |
| Total Debt/Mcap(x) | 0.09 | 0.07 | 0.02 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0.01 | 0.01 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 45.07 | 45.17 | 45.17 | 45.17 | 45.17 | 45.18 | 45.18 | 45.21 | 45.22 | 45.22 |
| FII | 8.06 | 8.46 | 8.63 | 9.67 | 11.22 | 9.79 | 8.78 | 8.31 | 7.45 | 7.5 |
| DII | 26.09 | 25.69 | 25.82 | 24.54 | 22.79 | 23.64 | 24.98 | 24.97 | 25.41 | 25.9 |
| Public | 20.79 | 20.68 | 20.38 | 20.62 | 20.82 | 21.39 | 21.06 | 21.51 | 21.92 | 21.38 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
| FII | 0.24 | 0.25 | 0.25 | 0.28 | 0.33 | 0.29 | 0.26 | 0.24 | 0.22 | 0.22 |
| DII | 0.77 | 0.76 | 0.76 | 0.72 | 0.67 | 0.7 | 0.74 | 0.74 | 0.75 | 0.76 |
| Public | 0.61 | 0.61 | 0.6 | 0.61 | 0.61 | 0.63 | 0.62 | 0.63 | 0.65 | 0.63 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.95 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +18% | +3% | +6% | +8% |
| Operating Profit CAGR | +47% | +1% | +1% | +10% |
| PAT CAGR | +54% | -6% | -6% | +8% |
| Share Price CAGR | -8% | 0% | -6% | +13% |
| ROE Average | +9% | +9% | +12% | +16% |
| ROCE Average | +13% | +12% | +16% | +21% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 45.07 | 45.17 | 45.17 | 45.17 | 45.17 | 45.18 | 45.18 | 45.21 | 45.22 | 45.22 |
| FII | 8.06 | 8.46 | 8.63 | 9.67 | 11.22 | 9.79 | 8.78 | 8.31 | 7.45 | 7.5 |
| DII | 26.09 | 25.69 | 25.82 | 24.54 | 22.79 | 23.64 | 24.98 | 24.97 | 25.41 | 25.9 |
| Public | 54.93 | 54.83 | 54.83 | 54.83 | 54.83 | 54.82 | 54.82 | 54.79 | 54.78 | 54.78 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
| FII | 0.24 | 0.25 | 0.25 | 0.28 | 0.33 | 0.29 | 0.26 | 0.24 | 0.22 | 0.22 |
| DII | 0.77 | 0.76 | 0.76 | 0.72 | 0.67 | 0.7 | 0.74 | 0.74 | 0.75 | 0.76 |
| Public | 1.62 | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.95 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.